137 related articles for article (PubMed ID: 10517190)
41. Clinical features and risk factors for mortality in Aeromonas bacteremic adults with hematologic malignancies.
Tsai MS; Kuo CY; Wang MC; Wu HC; Chien CC; Liu JW
J Microbiol Immunol Infect; 2006 Apr; 39(2):150-4. PubMed ID: 16604248
[TBL] [Abstract][Full Text] [Related]
42. Incidence, risk factors, and outcome of bloodstream infections during the pre-engraftment phase in 521 allogeneic hematopoietic stem cell transplantations.
Blennow O; Ljungman P; Sparrelid E; Mattsson J; Remberger M
Transpl Infect Dis; 2014 Feb; 16(1):106-14. PubMed ID: 24372809
[TBL] [Abstract][Full Text] [Related]
43. Staphylococcus aureus bacteremia in patients with hematologic malignancies: a retrospective case-control study.
Venditti M; Falcone M; Micozzi A; Carfagna P; Taglietti F; Serra PF; Martino P
Haematologica; 2003 Aug; 88(8):923-30. PubMed ID: 12935981
[TBL] [Abstract][Full Text] [Related]
44. Microbiology and mortality of pediatric febrile neutropenia in El Salvador.
Gupta S; Bonilla M; Gamero M; Fuentes SL; Caniza M; Sung L
J Pediatr Hematol Oncol; 2011 May; 33(4):276-80. PubMed ID: 21516023
[TBL] [Abstract][Full Text] [Related]
45. A prospective study of Gram-negative bacteremia in children.
Levy I; Leibovici L; Drucker M; Samra Z; Konisberger H; Ashkenazi S
Pediatr Infect Dis J; 1996 Feb; 15(2):117-22. PubMed ID: 8822283
[TBL] [Abstract][Full Text] [Related]
46. Risk factors associated with complications in patients with chemotherapy-induced febrile neutropenia in emergency department.
Lynn JJ; Chen KF; Weng YM; Chiu TF
Hematol Oncol; 2013 Dec; 31(4):189-96. PubMed ID: 23303687
[TBL] [Abstract][Full Text] [Related]
47. Pattern of bloodstream infections in patients with hematological malignancies in a tertiary care centre.
Bansal S; Advani SH
Indian J Cancer; 2014; 51(4):447-9. PubMed ID: 26842155
[TBL] [Abstract][Full Text] [Related]
48. Epidemiology, Management, and Risk-Adjusted Mortality of ICU-Acquired Enterococcal Bacteremia.
Ong DS; Bonten MJ; Safdari K; Spitoni C; Frencken JF; Witteveen E; Horn J; Klein Klouwenberg PM; Cremer OL;
Clin Infect Dis; 2015 Nov; 61(9):1413-20. PubMed ID: 26179013
[TBL] [Abstract][Full Text] [Related]
49. Risk factors for hospital-acquired bacteremia.
Yoshida T; Tsushima K; Tsuchiya A; Nishikawa N; Shirahata K; Kaneko K; Ito K; Kawakami H; Nakagawa S; Suzuki T; Kubo K; Ikeda S
Intern Med; 2005 Nov; 44(11):1157-62. PubMed ID: 16357453
[TBL] [Abstract][Full Text] [Related]
50. Nosocomial Gram-negative bacteremia in intensive care: epidemiology, antimicrobial susceptibilities, and outcomes.
Sligl WI; Dragan T; Smith SW
Int J Infect Dis; 2015 Aug; 37():129-34. PubMed ID: 26159847
[TBL] [Abstract][Full Text] [Related]
51. Impact of underlying diseases on the clinical characteristics and outcome of primary pyomyositis.
Chiu SK; Lin JC; Wang NC; Peng MY; Chang FY
J Microbiol Immunol Infect; 2008 Aug; 41(4):286-93. PubMed ID: 18787734
[TBL] [Abstract][Full Text] [Related]
52. [Gram-negative bacteremia in neutropenic patients with hematologic disorders. Experiences with prophylactic use of fluoroquinolones].
Sinkó J; Cser V; Konkoly Thege M; Masszi T
Orv Hetil; 2011 Jul; 152(27):1063-7. PubMed ID: 21676672
[TBL] [Abstract][Full Text] [Related]
53. Isolated pathogens and clinical outcomes of adult bacteremia in the emergency department: a retrospective study in a tertiary Referral Center.
Kao CH; Kuo YC; Chen CC; Chang YT; Chen YS; Wann SR; Liu YC
J Microbiol Immunol Infect; 2011 Jun; 44(3):215-21. PubMed ID: 21524617
[TBL] [Abstract][Full Text] [Related]
54. Sources and outcome of bloodstream infections in cancer patients: the role of central venous catheters.
Raad I; Hachem R; Hanna H; Bahna P; Chatzinikolaou I; Fang X; Jiang Y; Chemaly RF; Rolston K
Eur J Clin Microbiol Infect Dis; 2007 Aug; 26(8):549-56. PubMed ID: 17582536
[TBL] [Abstract][Full Text] [Related]
55. Epidemiology of bacteremia and factors associated with multi-drug-resistant gram-negative bacteremia in hematopoietic stem cell transplant recipients.
Oliveira AL; de Souza M; Carvalho-Dias VM; Ruiz MA; Silla L; Tanaka PY; Simões BP; Trabasso P; Seber A; Lotfi CJ; Zanichelli MA; Araujo VR; Godoy C; Maiolino A; Urakawa P; Cunha CA; de Souza CA; Pasquini R; Nucci M
Bone Marrow Transplant; 2007 Jun; 39(12):775-81. PubMed ID: 17438585
[TBL] [Abstract][Full Text] [Related]
56. The clinical impact of antibacterial prophylaxis and cycling antibiotics for febrile neutropenia in a hematological malignancy and transplantation unit.
Craig M; Cumpston AD; Hobbs GR; Devetten MP; Sarwari AR; Ericson SG
Bone Marrow Transplant; 2007 Apr; 39(8):477-82. PubMed ID: 17322937
[TBL] [Abstract][Full Text] [Related]
57. Septicemia and septic shock in pediatric patients: 140 consecutive cases on a pediatric hematology-oncology service.
Aledo A; Heller G; Ren L; Gardner S; Dunkel I; McKay SW; Flombaum C; Brown AE
J Pediatr Hematol Oncol; 1998; 20(3):215-21. PubMed ID: 9628432
[TBL] [Abstract][Full Text] [Related]
58. Gram-negative organisms predominate in Hickman line-related infections in non-neutropenic patients with hematological malignancies.
Chee L; Brown M; Sasadeusz J; MacGregor L; Grigg AP
J Infect; 2008 Apr; 56(4):227-33. PubMed ID: 18342947
[TBL] [Abstract][Full Text] [Related]
59. [Bacteremia due to vancomycin-resistant enterococci in neutropenic cancer patients].
Marron A; Carratalà J; Ayats J; Fernández de Sevilla A; Domínguez MA; Liñares J; Gudiol F
Med Clin (Barc); 1998 Dec; 111(20):761-4. PubMed ID: 9922964
[TBL] [Abstract][Full Text] [Related]
60. Impact of fluoroquinolone prophylaxis on reduced infection-related mortality among patients with neutropenia and hematologic malignancies.
Reuter S; Kern WV; Sigge A; Döhner H; Marre R; Kern P; von Baum H
Clin Infect Dis; 2005 Apr; 40(8):1087-93. PubMed ID: 15791505
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
